Search Results - "Culler, M. D"

Refine Results
  1. 1
  2. 2
  3. 3

    Somatostatin Dramatically Stimulates Growth Hormone Release from Primate Somatotrophs Acting at Low Doses Via Somatostatin Receptor 5 and Cyclic AMP by Córdoba-Chacón, J., Gahete, M. D., Culler, M. D., Castaño, J. P., Kineman, R. D., Luque, R. M.

    Published in Journal of neuroendocrinology (01-03-2012)
    “…Somatostatin and cortistatin have been shown to act directly on pituitary somatotrophs to inhibit growth hormone (GH) release. However, previous results from…”
    Get full text
    Journal Article
  4. 4

    Somatostatin Inhibits Tumor Angiogenesis and Growth via Somatostatin Receptor-3-Mediated Regulation of Endothelial Nitric Oxide Synthase and Mitogen-Activated Protein Kinase Activities by Florio, T, Morini, M, Villa, V, Arena, S, Corsaro, A, Thellung, S, Culler, M. D, Pfeffer, U, Noonan, D. M, Schettini, G, Albini, A

    Published in Endocrinology (Philadelphia) (01-04-2003)
    “…Somatostatin was reported to inhibit Kaposi’s sarcoma (KS) cell (KS-Imm) xenografts through an antiangiogenic activity. Here, we show that somatostatin blocks…”
    Get full text
    Journal Article
  5. 5

    Somatostatin and dopamine receptor interaction in prostate and lung cancer cell lines by Arvigo, M, Gatto, F, Ruscica, M, Ameri, P, Dozio, E, Albertelli, M, Culler, M D, Motta, M, Minuto, F, Magni, P, Ferone, D

    Published in Journal of endocrinology (01-12-2010)
    “…Somatostatin analogues inhibit in vitro cell proliferation via specific membrane receptors (SSTRs). Recent studies on transfected cell lines have shown a…”
    Get full text
    Journal Article
  6. 6

    Endogenous Ghrelin Regulates Episodic Growth Hormone (GH) Secretion by Amplifying GH Pulse Amplitude: Evidence from Antagonism of the GH Secretagogue-R1a Receptor by Zizzari, P, Halem, H, Taylor, J, Dong, J. Z, Datta, R, Culler, M. D, Epelbaum, J, Bluet-Pajot, M. T

    Published in Endocrinology (Philadelphia) (01-09-2005)
    “…Ghrelin was purified from rat stomach as an endogenous ligand for the GH secretagogue (GHS) receptor. As a GHS, ghrelin stimulates GH release, but it also has…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Role of the corticotropin-releasing factor receptor type 2 in the control of food intake in mice: a meal pattern analysis by Tabarin, A., Diz-Chaves, Y., Consoli, D., Monsaingeon, M., Bale, T. L., Culler, M. D., Datta, R., Drago, F., Vale, W. W., Koob, G. F., Zorrilla, E. P., Contarino, A.

    Published in The European journal of neuroscience (01-10-2007)
    “…The actions of corticotropin‐releasing factor (CRF) and related peptides are mediated by two receptors (CRF1 and CRF2). The respective role of each subtype in…”
    Get full text
    Journal Article
  10. 10
  11. 11

    The effect of emulsifying salts on the turbidity of a diluted milk system with varying pH and protein concentration by Culler, M D, Saricay, Y, Harte, F M

    Published in Journal of dairy science (01-06-2017)
    “…Solutions of 10 commonly used emulsifying salts (ES) listed in the Code of Federal Regulations (21CFR133.179) for pasteurized process cheese were tested for…”
    Get more information
    Journal Article
  12. 12

    Quantitative and Functional Expression of Somatostatin Receptor Subtypes in Human Prolactinomas by Jaquet, P, Ouafik, L, Saveanu, A, Gunz, G, Fina, F, Dufour, H, Culler, M D, Moreau, J P, Enjalbert, A

    “…ABSTRACTRecently, it was demonstrated that somatostatin analogs preferential for the SSTR5 subtype suppress PRL release from prolactinoma cell cultures by…”
    Get full text
    Journal Article
  13. 13

    Somatostatin-dopamine chimeras: a novel approach to treatment of neuroendocrine tumors by Culler, M D

    Published in Hormone and metabolic research (01-11-2011)
    “…A combination of basic research observations concerning the interaction of somatostatin (SST) and dopamine (DA) receptors, and clinical reports of enhanced…”
    Get more information
    Journal Article
  14. 14

    Characterization of New Selective Somatostatin Receptor Subtype-2 (sst2) Antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH Release in Anesthetized Male Rats after Short-Term High-Dose Dexamethasone Treatment by Tulipano, G, Soldi, D, Bagnasco, M, Culler, M. D, Taylor, J. E, Cocchi, D, Giustina, A

    Published in Endocrinology (Philadelphia) (01-04-2002)
    “…We here report a pharmacological characterization of two new somatostatin (SS) receptor subtype-2 (sst2) selective antagonists by evaluating their GH-releasing…”
    Get full text
    Journal Article
  15. 15

    Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro by Zatelli, M C, Piccin, D, Tagliati, F, Bottoni, A, Ambrosio, M R, Margutti, A, Scanarini, M, Bondanelli, M, Culler, M D, Uberti, E C degli

    Published in Journal of molecular endocrinology (01-10-2005)
    “…Dopamine (DA) and somatostatin (SRIF) receptor agonists inhibit growth hormone (GH) secretion by pituitary adenomas. We investigated DA subtype 2 receptor…”
    Get full text
    Journal Article
  16. 16

    Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation by Shimon, I, Taylor, J E, Dong, J Z, Bitonte, R A, Kim, S, Morgan, B, Coy, D H, Culler, M D, Melmed, S

    Published in The Journal of clinical investigation (15-02-1997)
    “…Somatostatin (SRIF), a hypothalamic inhibitor of pituitary growth hormone (GH) and thyroid-stimulating hormone (TSH) secretion, binds to five distinct receptor…”
    Get full text
    Journal Article
  17. 17

    Novel ghrelin analogs with improved affinity for the GH secretagogue receptor stimulate GH and prolactin release from human pituitary cells by Rubinfeld, H, Hadani, M, Taylor, JE, Dong, JZ, Comstock, J, Shen, Y, Deoliveira, D, Datta, R, Culler, MD, Shimon, I

    Published in European journal of endocrinology (01-12-2004)
    “…OBJECTIVE: Ghrelin, a recently identified 28-amino acid peptide is a potent GH secretagogue (GHS) produced predominantly by the stomach. Ghrelin stimulates GH…”
    Get full text
    Journal Article
  18. 18

    Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues by Ludvigsen, E., Stridsberg, M., Taylor, J.E., Culler, M.D., Öberg, K., Janson, E.T., Sandler, S.

    Published in Regulatory peptides (10-01-2007)
    “…Somatostatin is an inhibitor of hormone secretion through specific receptors (sst 1–5). The aim of this study was to investigate the putative regulatory role…”
    Get full text
    Journal Article
  19. 19

    The effect of selective sst1, sst2, sst5 somatostatin receptors agonists, a somatostatin/dopamine (SST/DA) chimera and bromocriptine on the “clinically non-functioning” pituitary adenomas in vitro by Gruszka, A., Kunert-Radek, J., Radek, A., Pisarek, H., Taylor, J., Dong, J.Z., Culler, M.D., Pawlikowski, M.

    Published in Life sciences (1973) (11-01-2006)
    “…The aim of the work was to investigate the effects of somatostatin analogs acting selectively on sst1 (BIM-23926), sst2 (BIM-23120) and sst5 (BIM-23206)…”
    Get full text
    Journal Article
  20. 20